Thoracentesis under clopidogrel is not associated with excessive bleeding events: a cohort study

BACKGROUND: Thoracentesis is a low-risk procedure for bleeding (approx. 2%). Data regarding safety of thoracentesis under treatment with clopidogrel is scarce, and current guidelines are not evidence based. We performed a retrospective study to evaluate the rate of bleeding complications of thoracen...

Descripción completa

Detalles Bibliográficos
Autores principales: Perl, Sivan, Bondarenco, Marina, Natif, Noam, Shpirer, Yitschak, Enghelberg, Sharon, Fox, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590472/
https://www.ncbi.nlm.nih.gov/pubmed/33109208
http://dx.doi.org/10.1186/s12931-020-01549-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590472/
https://www.ncbi.nlm.nih.gov/pubmed/33109208
http://dx.doi.org/10.1186/s12931-020-01549-z

Ejemplares similares